NOVACYT (ALNOV.PA) Stock Price & Overview
EPA:ALNOV • FR0010397232
Current stock price
The current stock price of ALNOV.PA is 0.387 EUR. Today ALNOV.PA is down by -0.13%. In the past month the price decreased by -2.52%. In the past year, price decreased by -29.25%.
ALNOV.PA Key Statistics
- Market Cap
- 27.334M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.50
- Dividend Yield
- N/A
ALNOV.PA Stock Performance
ALNOV.PA Stock Chart
ALNOV.PA Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to ALNOV.PA. When comparing the yearly performance of all stocks, ALNOV.PA is a bad performer in the overall market: 90.47% of all stocks are doing better.
ALNOV.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ALNOV.PA. The financial health of ALNOV.PA is average, but there are quite some concerns on its profitability.
ALNOV.PA Earnings
ALNOV.PA Forecast & Estimates
ALNOV.PA Groups
Sector & Classification
ALNOV.PA Financial Highlights
Over the last trailing twelve months ALNOV.PA reported a non-GAAP Earnings per Share(EPS) of -0.5. The EPS increased by 17.85% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -48.32% | ||
| ROE | -74.44% | ||
| Debt/Equity | 0.24 |
ALNOV.PA Ownership
ALNOV.PA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ARGX | ARGENX SE | 25.34 | 38.17B | ||
| 1AE | ARGENX SE | 25.35 | 38.17B | ||
| 22UA | BIONTECH SE-ADR | N/A | 19.092B | ||
| ABVX | ABIVAX SA | N/A | 8.477B | ||
| 2X1 | ABIVAX SA | N/A | 8.445B | ||
| GLPG | GALAPAGOS NV | N/A | 1.877B | ||
| GXE | GALAPAGOS NV | N/A | 1.877B | ||
| NANO | NANOBIOTIX | N/A | 1.42B | ||
| 6IV | INVENTIVA SA | N/A | 1.087B | ||
| IVA | INVENTIVA SA | N/A | 1.071B | ||
| PHIL | PHILOGEN SPA | 18.25 | 657.9M | ||
| XUP | GENFIT | 917.65 | 468.027M | ||
| GNFT | GENFIT | 860.29 | 429.025M |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Paris Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
About ALNOV.PA
Company Profile
Novacyt SAS is a diagnostics company, which engages in the business of developing, producing, and selling vitro and molecular diagnostic tests and products for a wide range of infectious diseases. The company is headquartered in Velizy-Villacoublay, Ile-De-France. The company went IPO on 2012-10-12. The firm develops and markets solutions dedicated to the field of liquid-based cytology and molecular biology. The company provides diagnostic products used in oncology, microbiology, haematology, and serology testing. The firm develops secure automated cytology named NovaPrep Processor System. The company offers a solution of cytological sampling to help in the detection of precancerous and cancerous lesions. The company creates bottles specifically dedicated to the optimization of cell collection. The Company’s range of products includes Bottle Gyn and No Gyn Bottle.
Company Info
IPO: 2012-10-12
NOVACYT
131 Boulevard Carnot, Le Vesinet
Velizy-Villacoublay ILE-DE-FRANCE FR
Employees: 234
Phone: 33139465104
NOVACYT / ALNOV.PA FAQ
What does NOVACYT do?
Novacyt SAS is a diagnostics company, which engages in the business of developing, producing, and selling vitro and molecular diagnostic tests and products for a wide range of infectious diseases. The company is headquartered in Velizy-Villacoublay, Ile-De-France. The company went IPO on 2012-10-12. The firm develops and markets solutions dedicated to the field of liquid-based cytology and molecular biology. The company provides diagnostic products used in oncology, microbiology, haematology, and serology testing. The firm develops secure automated cytology named NovaPrep Processor System. The company offers a solution of cytological sampling to help in the detection of precancerous and cancerous lesions. The company creates bottles specifically dedicated to the optimization of cell collection. The Company’s range of products includes Bottle Gyn and No Gyn Bottle.
Can you provide the latest stock price for NOVACYT?
The current stock price of ALNOV.PA is 0.387 EUR. The price decreased by -0.13% in the last trading session.
What is the dividend status of NOVACYT?
ALNOV.PA does not pay a dividend.
How is the ChartMill rating for NOVACYT?
ALNOV.PA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Which stock exchange lists ALNOV stock?
ALNOV.PA stock is listed on the Euronext Paris exchange.
Can you provide the sector and industry classification for NOVACYT?
NOVACYT (ALNOV.PA) operates in the Health Care sector and the Biotechnology industry.
Who owns NOVACYT?
You can find the ownership structure of NOVACYT (ALNOV.PA) on the Ownership tab.